Skip to content

Glycemic Excursion Minimization (GEM) to Outshine Health Disparities

Glycemic Excursion Minimization (GEM) to Outshine Health Disparities: RCT

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06236581
Acronym
GEM
Enrollment
25
Registered
2024-02-01
Start date
2024-06-20
Completion date
2024-12-31
Last updated
2024-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Black, Continuous glucose monitoring, physical activity, carbohydrate

Brief summary

The purpose of this study is to see if the GEM intervention is acceptable and helpful to Black adults with type 2 diabetes. The GEM intervention (coaching to reduce carbohydrate intake and increase physical activity after meals, with feedback from a continuous glucose monitor, CGM) might improve blood glucose levels, reduce diabetes distress, and increase empowerment and confidence in managing diabetes.

Detailed description

The purpose of the study is to test the feasibility, acceptability, and initial efficacy of the tailored GEM intervention among adult Black patients with type 2 diabetes, who are not on insulin or secretagogues.

Interventions

BEHAVIORALGEM Intervention

Lifestyle coaching

Sponsors

University of Virginia
CollaboratorOTHER
University of Colorado, Denver
CollaboratorOTHER
Catherine Davis
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized controlled trial, intervention vs. waitlist

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* type 2 diabetes * capable of making dietary and physical activity changes

Exclusion criteria

* on insulin or secretagogue * on medications that impede weight loss (e.g., prednisone) * pregnant or planning pregnancy in the next 2 months * no history of moderate to severe hypoglycemia

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline on percent time in range from continuous glucose monitor at post-interventionBaseline week and post-intervention week. From baseline week to the week after end of intervention or waitlist period, up to 6 weeksDifference in percent of time in range (70-180 mg/dL) from continuous glucose monitor data. Change = post intervention week minus baseline week.

Countries

United States

Contacts

Primary ContactCatherine L Davis, PhD
katie.davis@augusta.edu706-721-4534

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026